Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease

Published:2011-05-23 Issue:10 Volume:171 Page:
ISSN:0003-9926
Container-title:Archives of Internal Medicine
language:en
Short-container-title:Arch Intern Med

Author:

Stephenson Anne,Seitz Dallas,Bell Chaim M.,Gruneir Andrea,Gershon Andrea S.,Austin Peter C.,Fu Longdi,Anderson Geoffrey M.,Rochon Paula A.,Gill Sudeep S.

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials);American Journal of Respiratory and Critical Care Medicine;2023-08-15

2. Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities;Drugs & Aging;2023-06-14

3. Diagnostic and therapeutic approaches for elderly asthma patients: the importance of multidisciplinary and multidimensional management;Expert Review of Respiratory Medicine;2023-05-18

4. The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis;Chronic Respiratory Disease;2023-01

5. Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy;International Journal of Clinical Pharmacy;2022-11-16